Skip to main content

Table 2 Mortality by comorbidity

From: Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study

Comorbidity HR (95%CI)a
Cervical cancer
Elixhauser (1 unit) 1.25 (1.11-1.40)
Elixhauser 0 1.00b
Elixhauser 1 1.29 (0.96-1.75)
Elixhauser 2 1.33 (0.83-2.13)
Elixhauser 3+ 2.17 (1.32-3.56)
Other mortality (not cervical cancer)
Elixhauser (1 unit) 1.46 (1.18-1.79)
Elixhauser 0 1.00b
Elixhauser 1 2.49 (1.39-4.44)
Elixhauser 2 2.62 (1.20-5.72)
Elixhauser 3+ 2.76 (1.04-7.30)
Total mortality
Elixhauser (1 unit) 1.28 (1.15-1.41)
Elixhauser 0 1.00b
Elixhauser 1 1.47 (1.13-1.92)
Elixhauser 2 1.48 (0.99-2.21)
Elixhauser 3+ 2.20 (1.41-3.41)
  1. a Adjusted for age, year of diagnosis, stage, ethnicity, socioeconomic position, and urban/rural residence
  2. b Reference category